| Identification | Back Directory | [Name]
2-chloro-N6-Cyclopentyladenosine (hydrate) | [CAS]
1217443-91-8 | [Synonyms]
2-chloro-N6-Cyclopentyladenosine (hydrate) | [Molecular Formula]
C15H22ClN5O5 | [MOL File]
1217443-91-8.mol | [Molecular Weight]
387.82 |
| Hazard Information | Back Directory | [Uses]
CCPA hemihydrate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1][2]. | [References]
[1] Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500. DOI:10.1016/j.drudis.2021.02.020
[2] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|